| J9271 | Injection, pembrolizumab, 1 mg | 7,000 | $40 | $301K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 63,750 | $1 | $63.8K |
| J0897 | Injection, denosumab, 1 mg | 3,300 | $20 | $59.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 210 | $120 | $24.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 130 | $100 | $13.4K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 1,780 | $10 | $10.7K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 70 | $150 | $10.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 150 | $70 | $10.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 180 | $60 | $9.7K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 140 | $70 | $9.1K |